https://www.selleckchem.com/pr....oducts/bay-1217389.h
6%), and colonoscopy with sigmoidoscopy (53, 15.8%). The numbers of procedures performed in 2018 and 2019 dropped by 48.8% and 54.8%, respectively, compared with those in 2020. During the COVID-19 outbreak, the main indications for endoscopy were melena (36.7%), hematemesis (30.6%), and hematochezia (10.2%). Of the endoscopic abnormalities detected, gastrointestinal bleeding was the most common 39 cases in 2018, 51 in 2019, and 35 in 2020. The impact of COVID-19 is substantial and caused dramatic reductions in endoscopic procedures
Like
Comment
Share
